Drug Makers Move To Dismiss Complaint Saying Sickle Cell Medication Caused Stroke
SAN FRANCISCO — Global Blood Therapeutics Inc. (GBT) and Pfizer Inc. tell a California federal court in an April 23 motion that an amended complaint alleging that Oxbryta (voxelotor), a prescription...To view the full article, register now.
Already a subscriber? Click here to view full article